Siatis Perry C

CIK 00019514001 companyNORTH CHICAGO, IL

SEC Profile

Transactions

Companies

Filings

CIK

0001951400

Recent Transactions

50 trades

Disposition to Issuer
AbbVie Inc.$ABBV
Option (Right to buy)
2025-03-03$144.54/sh−2,918→ 0 total
Disposition to Issuer
AbbVie Inc.$ABBV
Option (Right to buy)
2025-03-03$149.62/sh−7,315→ 7,314 total
Disposition to Issuer
AbbVie Inc.$ABBV
Option (Right to buy)
2025-03-03$175.28/sh−7,775→ 15,549 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-03-03$175.28/sh+7,775→ 22,627 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-03-03$144.54/sh+2,918→ 7,537 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-03-03$149.62/sh+7,315→ 14,852 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-03-03$210.00/sh−18,008→ 4,619 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-28$206.62/sh−6,811→ 4,982 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-28$205.38/sh−2,718→ 11,793 total
Tax Payment
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-28$205.02/sh−7,870→ 14,511 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-28$207.19/sh−363→ 4,619 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-20$197.40/sh−1,784→ 26,375 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-20$198.12/sh−3,994→ 22,381 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-13+1,844→ 16,737 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-13+5,792→ 22,529 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-13+5,630→ 28,159 total
Award
AbbVie Inc.$ABBV
Option (Right to buy)
2025-02-13+21,875→ 21,875 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2025-02-13+4,496→ 14,893 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-29$177.05/sh−6,504→ 13,784 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-29$178.04/sh−3,387→ 10,397 total
Tax Payment
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-28$178.99/sh−7,885→ 20,288 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2024-02-23$149.62/sh+7,315→ 14,629 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-23$144.54/sh+2,919→ 31,092 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-23$105.92/sh+3,519→ 34,611 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-23$177.51/sh−13,753→ 28,173 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-23$149.62/sh+7,315→ 41,926 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2024-02-23$144.54/sh+2,919→ 2,919 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2024-02-23$105.92/sh+3,519→ 0 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-15+8,022→ 18,399 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-15+2,138→ 20,537 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-15+1,844→ 22,381 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-15+5,792→ 28,173 total
Award
AbbVie Inc.$ABBV
Option (Right to buy)
2024-02-15+23,324→ 23,324 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-02$144.54/sh+2,919→ 13,296 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2024-02-02$144.54/sh−2,919→ 5,837 total
Disposition to Issuer
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2024-02-02$170.00/sh−2,919→ 10,377 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2023-04-03$105.92/sh−3,520→ 3,520 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2023-04-03$105.92/sh+3,520→ 13,897 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2023-04-03$160.00/sh−3,520→ 10,377 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2023-03-01$153.06/sh−11,330→ 11,182 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2023-03-01$153.38/sh−805→ 10,377 total
Tax Payment
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2023-02-28$154.28/sh−9,656→ 22,512 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2023-02-21$151.29/sh−3,933→ 32,168 total
Exercise/Conversion
AbbVie Inc.$ABBV
Option (Right to buy)
2023-02-21$93.50/sh−7,364→ 0 total
Exercise/Conversion
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2023-02-21$93.50/sh+7,364→ 39,532 total
Sale
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2023-02-21$150.73/sh−3,431→ 36,101 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2023-02-16+1,846→ 32,168 total
Award
AbbVie Inc.$ABBV
Option (Right to buy)
2023-02-16+21,944→ 21,944 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2023-02-16+14,437→ 24,814 total
Award
AbbVie Inc.$ABBV
Common Stock, $0.01 par value
2023-02-16+3,368→ 28,182 total

Companies

AbbVie Inc.
EVP, GC AND SECRETARY
$ABBV

Recent Filings

Address

1 N. WAUKEGAN ROAD

NORTH CHICAGO, IL, 60064

View on SEC.gov